LYVE1 Antikörper (AA 24-228)
Kurzübersicht für LYVE1 Antikörper (AA 24-228) (ABIN2745545)
Target
Alle LYVE1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 24-228
-
Verwendungszweck
- anti-LYVE-1, pAb
-
Spezifität
- Recognizes mouse and rat LYVE-1.
-
Produktmerkmale
- Polyclonal Antibody. Recognizes mouse and rat LYVE-1. Source: Rabbit. Applications: ELISA, FACS, IHC, WB. Lyophilized. LYVE-1 has been identified as a major receptor for HA (extracellular matrix glycosaminoglycan hyaluronan) on the lymph vessel wall. Like CD44, the LYVE-1 Molecule binds both soluble and immobilized HA. However, unlike CD44, the LYVE-1 Molecule co-localizes with HA on the luminal face of the lymph vessel wall and is completely absent from blood vessels. Hence, LYVE-1 is the first lymph-specific HA receptor to be characterized and is a uniquely powerful marker for lymph vessels themselves.
-
Aufreinigung
- Antigen affinity purified.
-
Reinheit
- Antigen affinity purified.
-
Immunogen
- Recombinant mouse soluble LYVE-1 (aa24-228).
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Centrifuge vial prior to opening. Reconstitute with sterile water to a concentration of 0.1-1.0 mg/mL.
-
Buffer
- Lyophilized.
-
Handhabung
- After opening, prepare aliquots and store at -20 °C.Avoid freeze/thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
+4°C
-20°C
Stable for at least 6 months after receipt when stored at -20°C.
-
Haltbarkeit
- 6 months
-
-
- LYVE1 (Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1))
-
Andere Bezeichnung
- Lyve1
-
Hintergrund
-
Alternate Names/Synonyms: Lymphatic Vessel Endothelial Hyaluronic Acid Receptor 1, CRSBP-1
Product Description: LYVE-1 has been identified as a major receptor for HA (extracellular matrix glycosaminoglycan hyaluronan) on the lymph vessel wall. Like CD44, the LYVE-1 Molecule binds both soluble and immobilized HA. However, unlike CD44, the LYVE-1 Molecule co-localizes with HA on the luminal face of the lymph vessel wall and is completely absent from blood vessels. Hence, LYVE-1 is the first lymph-specific HA receptor to be characterized and is a uniquely powerful marker for lymph vessels themselves.
-
UniProt
- Q8BHC0
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-